biotech

The month-long programme provides intensive, hands-on training in wet lab facilities, offering real-world experience in…

Innovator drug deals involving Chinese biopharma reach $41.5 billion as licensing overtakes M&A for pipeline expansion, notes…

The new facility expands peptide synthesis and discovery capabilities for pharma and biotech companies

Partnership aims to develop efficient and flexible biopharmaceutical production processes

Fund targets INR 200 crore corpus with focus on biotech, pharma, and medical

Key growth areas across subsectors include contract manufacturing and research, and innovation-driven biotech

Amit Mookim, CEO, Immuneel Therapeutics urges the govt to focus on establishing a strong compliance framework and expediting…

In a free wheeling conversation with Viveka Roychowdhury, Dr Dhananjay Patankar, biopharma consultant, explains why Indian…

While mega-cap companies dominate the GLP-1R market and are expected to maintain their stronghold in 2030, three smaller biotechs…

New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari, India and Suzhou,…